1. Home
  2. MFC vs BSX Comparison

MFC vs BSX Comparison

Compare MFC & BSX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Manulife Financial Corporation

MFC

Manulife Financial Corporation

N/A

Current Price

$41.04

Market Cap

67.5B

Sector

Finance

ML Signal

N/A

Logo Boston Scientific Corporation

BSX

Boston Scientific Corporation

N/A

Current Price

$42.36

Market Cap

68.0B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
MFC
BSX
Founded
1887
1979
Country
Canada
United States
Employees
37000
N/A
Industry
Life Insurance
Medical/Dental Instruments
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
67.5B
68.0B
IPO Year
2002
2010

Fundamental Metrics

Financial Performance
Metric
MFC
BSX
Price
$41.04
$42.36
Analyst Decision
Buy
Analyst Count
0
31
Target Price
N/A
★ $49.60
AVG Volume (30 Days)
1.8M
★ 17.8M
Earning Date
11-04-2026
10-28-2026
Dividend Yield
★ 3.31%
N/A
EPS Growth
N/A
★ 55.20
EPS
N/A
★ 1.92
Revenue
N/A
★ $9,076,000,000.00
Revenue This Year
$91.93
$4.46
Revenue Next Year
N/A
N/A
P/E Ratio
★ $16.52
$22.39
Revenue Growth
N/A
★ 12.49
52 Week Low
$32.66
$39.57
52 Week High
$46.19
$101.91

Technical Indicators

Market Signals
Indicator
MFC
BSX
Relative Strength Index (RSI) 31.75 42.76
Support Level $39.48 $39.57
Resistance Level $41.43 $46.31
Average True Range (ATR) 0.82 1.49
MACD -0.36 -0.17
Stochastic Oscillator 1.33 1.57

Price Performance

Historical Comparison
MFC
BSX

About MFC Manulife Financial Corporation

Manulife Financial is one of the Big Three Canadian life insurers. The firm provides life insurance, annuities, asset management, and wealth management products to individuals and group customers in Canada, the United States, and Asia. The Canadian business segment contributes approximately 21% of 2025 adjusted earnings. The Asia segment operates across 12 countries and contributes around 38% of earnings, with a significant presence in Hong Kong and Singapore. The US business, which primarily operates under the John Hancock brand, contributes about 16% of earnings. Manulife's global asset and wealth management business contributes approximately 25% of its earnings. The firm had around CAD 1.2 trillion in assets under management and administration as of the end of June 2026.

About BSX Boston Scientific Corporation

Boston Scientific focuses on less invasive medical devices that are inserted into the human body through small openings or cuts. It manufactures products for use in angioplasty, blood clot filtration, kidney stone management, cardiac rhythm management, catheter-directed ultrasound imaging, upper gastrointestinal tract diagnostics, interventional oncology, neuromodulation for chronic pain, and treatment of incontinence. The firm markets its devices to healthcare professionals and institutions globally. Foreign sales account for roughly 36% of the firm's total sales.

Share on Social Networks: